Skip to main content
Breadcrumb

Fredrik Bäckhed

PROFESSOR

Department of Molecular and Clinical
Medicine
Visiting address
Wallenberglab
Göteborg
Postal address
Su sahlgrenska
41345 Göteborg

About Fredrik Bäckhed

Fredrik Bäckhed, an expert in cellular microbiology and mouse physiology, combines clinical oriented research with gnotobiotic mouse models to address the role of the normal gut microbiota in metabolic diseases.

Professor Bäckhed has received several prestigious awards.

Rewards and distinctions

  • Minkowski prize (2018)
  • Appointed Torsten Söderberg Professor in Medicine (2017)
  • Elected to The Royal Swedish Academy of
  • Engineering Sciences (2015)
  • Göran Gustafsson Award in Medicine (2014)
  • ERC consolidator (2013)
  • The “Prince Daniel´s Grant to young promising researchers”(2013)
  • The DuPont Young Professor Award (2013)
  • The DPLU/LUDC Nordic Prize for an Outstanding
  • Young Diabetes Investigator (2010)
  • Dr Eric K Fernström Foundation’s Prize to Young
  • Swedish Scientists (2010)
  • Ingvar Carlsson Award (2006)
  • Chorafas Prize (2003)

He has been elected to the Young Academy of Sweden hosted by the Royal Academy of Sciences (2011) Royal Academy of Engineering (2016) and Royal Academy of Sciences (2017).

Highly cited researcher

Fredrik Bäckhed is one of the world´s most cited researchers in 2019, according to Web of Science, Clarivate Analytics. Read more here (NB: in Swedish)

For a profile about Professor Bäckhed and his group, please read the article from Research Media (opens in a new window):

Gut Instincts and Unravelling the human gut

Main research

The human intestinal tract is inhabited by 10-100 trillion microbes consisting of thousands of different species, collectively called the microbiota. The microbial community has an immense capacity to affect host biology and is fundamental to many processes, including the development of our immune system, processing of otherwise indigestible dietary polysaccharides, and vitamin and hormone production. The gut microbiome (collection of all microbial genes) encodes perhaps 1000-fold more genes than the human genome and provides us with numerous complementary functions and activities.

The overall aim of our research is to clarify the role of bacteria associated with the human body in the development of metabolic diseases, with particular emphasis on diabetes, steatosis, and atherosclerosis as well as delineating whether altered gut microbiota contributes to the beneficial effects of bariatric surgery. We use a translational approach that involves both human cohorts − to identify differences in microbial communities associated with the body in disease states − and germ-free mice − to investigate the underlying molecular mechanisms promoted by specific bacteria.

Key Publications

Group members

Team leaders

  • Louise Mannerås Holm, PhD
  • Louise Olofsson, PhD
  • Robert Caesar, PhD
  • Thomas Greiner, PhD
  • Valentina Tremaroli, PhD

Postdoctoral Fellow

  • Alba Carreras, PhD
  • Estelle Grasset, PhD
  • Tanweer Khan, PhD
  • Ara Koh, PhD
  • Petia Kovatcheva, PhD (back 2019)
  • Kim Krautkramer, MD PhD
  • Kassem Makki, PhD
  • Antonio Molinaro, MD PhD
  • Marc Schöler, MD
  • Tony Wu, PhD

PhD Student

  • Christina Heiss
  • Lisa Olsson
  • Kristien Fluitmann

Research Associate

  • Carina Arvidsson
  • Ulrica Enqvist
  • Louise Hellden
  • Anna Hallén
  • Robert Jakubowicz
  • Manuela Krämer
  • Oskar Persson

Bioinformatician

  • Harald Brolin
  • Meenakshi Pradhan

Metabolomics/Lipidomics

  • Marcus Ståhlman, PhD
  • Per-Olof Bergh

Laboratory Manager

  • Annika Lundqvist, PhD

Administrator

  • Christel Jansson
  • Olivia Jungstrand